Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis. Gargiulo L, Costanzo A. Br J Dermatol 2025 May 23:ljaf186. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gargiulo L, Costanzo A. Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis. Br J Dermatol 2025 May 23:ljaf186. doi: 10.1093.
PMID: 40406970